Abstract:BACKGROUND: Cholecystokinin (CCK) has been found to be a growth stimulant through its special receptor pathway, especially for gastrointestinal malignancies. Although the CCK-1 receptor has been shown to be highly expressed in resected human pancreatic cancer samples, its role is less clear.OBJECTIVE: The aim of this in vitro study was to investigate the CCK-1 receptor expression and the function of the CCK CCK-1 receptor pathway in the human pancreatic adenocarcinoma cell line, Mia PaCa-2.METHODS: The expression of the CCK-1 receptor in Mia PaCa-2 cells was detected by reverse-transcriptase polymerase chain reaction and flow cytometry. CCK-1 receptor agonist CCK-8S (the major transmitter form of CCK) and antagonist lorglumide were cultured respectively with Mia PaCa-2. Three groups were created for this study: CCK-8S group (Mia PaCa-2 cells treated with CCK-8S), lorglumide group (Mia PaCa-2 cells treated with lorglumide), and the control group (Mia PaCa-2 cells alone). Investigators were blinded to group designation. 3-[4,5-Dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry were used to detect the cell growth, cell cycle, and apoptosis. Apoptosis index rate was measured by terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick-end labeling. Cell invasion ability was observed by invasion assay. Expression of matrix metalloproteinase-2 (MMP-2) was measured by Western blotting.RESULTS: Mia PaCa-2 cells were found to express the CCK-1 receptor. Compared with the control group (70.2% [1.5%]), CCK-8S was associated with significant mean (SD) cell proliferation (85.1% [1.7%]; P = 0.039), and the ratio in the S stage of the cell cycle increased significantly (50.5% [1.7%] vs 42.2% [1.4%]; P = 0.021). CCK-8S was also associated with increased Mia PaCa-2 cell invasion ability (123.8 [1.7] vs 102.1 [5.8]; P = 0.005 vs control). Compared with the control group, lorglumide was associated with significantly inhibited cell growth (52.1% [1.8%]; P = 0.002) and cell invasion (77.6% [1.2%]; P = 0.003). Lorglumide also induced G0/G1 cell cycle arrest and apoptosis (27.1% [3.5%] vs 3.7% [0.6%]; P = 0.003 vs control). The change of invasion ability appeared to be mediated by MMP-2 expression, which was upregulated by CCK-8S and downregulated by lorglumide.CONCLUSION: The findings of this in vitro study suggest that CCK may exert a trophic action on the Mia PaCa-2 cell line, while lorglumide inhibited the cell growth and invasion. (Curr Ther Res Clin Exp. 2010;71:239-251) (C) 2010 Excerpta Medica Inc.

Expression and function of cholecystokinin-A receptor in human pancreatic adenocarcinoma cell line Panc-1

Integrated Bioinformatics Analysis Identified COL11A1 As an Immune Infiltrates Correlated Prognosticator in Pancreatic Adenocarcinoma

Effects of Lorglumide on Growth and Invasion of Human Pancreatic Cancer Cell Line Mia PaCa-2 in Vitro Through the Cholecystokinin-Cholecystokinin-1 Receptor Pathway.

Epac1 is Involved in Cell Cycle Progression in Lung Cancer Through PKC and Cx43 Regulation

Effect of Cholecystokinin and Gastrin on Proliferation of Cholangiocarcinoma Cell Growing in Vivo

Lncrna-Cche1 is Involved in Migration and Invasion but Not in Proliferation of Pancreatic Adenocarcinoma Cells Possibly by Interacting with ROCK1.

GAS/CCK-2R and function of its antagonists in treatment of the pancreatic cancer

Effect of phospholipase D1 on proliferation of pancreatic cancer cells

Overexpressions of Ck2 Beta and Xiap Are Associated with Poor Prognosis of Patients with Cholangiocarcinoma

Study on Effect of Cholecystokinin-a Receptor Antagonist L-364, 718 in Experimental Pancreas Regeneration Model

The Modulation of Gastrin and CCK on Gene Expression of Bcl-2 and Bax of Bile Duct Cancer Cells

Effects of Gastrin and Cholecystokinin on the Threshold for Apoptosis in Cholangiocarcinoma Cell Line QBC939

In Vitro Study on Stromal Cell Derived Factorl/chemokine Receptor 4 Axis That Involved in the Invasion of Human Pancreatic Cancer Cells

Re-expression of Cell Adhesion Molecule Inhibits Growth and Induces Apoptosis of Human Pancreatic Cancer Cell Line PANC-1

Chemokine Receptor CXCR4 Enhances Proliferation in Pancreatic Cancer Cells Through AKT and ERK Dependent Pathways

Effect of Dapk1 Gene on Proliferation, Migration, and Invasion of Carcinoma of Pancreas Bxpc-3 Cell Line

Expression of E-cadherin and PCNA in pancreatic adenocarcinoma and their clinic significance

Experimental study on the pancreatic cancer G1/S phase arrest byβ2-adrenergic antagonist

Expression of KL-6/MUC1 in Pancreatic Ductal Carcinoma and Its Potential Relationship with Β-Catenin in Tumor Progression.

Effect of LncRNA LINC00857 Knockdown on Migration, Proliferation and Apoptosis of Pancreatic Cancer PANC-1 Cells

Podoplanin is an Important Stromal Prognostic Marker in Perihilar Cholangiocarcinoma